Angiografin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Angiografin
P
- Pacerone (amiodarone)
- pamidronate
- Pamprin All Day Relief (naproxen)
- PediaCare Children's IB Ibuprofen Pain Reliever/Fever Reducer (ibuprofen)
- PediaCare Infants' IB Ibuprofen Pain Reliever/Fever Reducer (ibuprofen)
- penbutolol
- penicillamine
- Pentacarinat (pentamidine)
- Pentam (pentamidine)
- Pentam 300 (pentamidine)
- pentamidine
- Pentasa (mesalamine)
- Penthrane (methoxyflurane)
- phenylbutazone
- pindolol
- piroxicam
- Platinol (cisplatin)
- Platinol-AQ (cisplatin)
- plazomicin
- Plendil (felodipine)
- Pluvicto (lutetium lu 177 vipivotide tetraxetan)
- polymyxin b
- polythiazide
- polythiazide / prazosin
- polythiazide / reserpine
- Ponstel (mefenamic acid)
- Posicor (mibefradil)
- PrandiMet (metformin / repaglinide)
- Prestalia (amlodipine / perindopril)
- Prevacid NapraPAC (lansoprazole / naproxen)
- Prevacid NapraPAC 375 (lansoprazole / naproxen)
- Prevacid NapraPAC 500 (lansoprazole / naproxen)
- Primacor (milrinone)
- Primacor I.V. (milrinone)
- Prinzide (hydrochlorothiazide / lisinopril)
- procainamide
- Procan SR (procainamide)
- Procanbid (procainamide)
- Procardia (nifedipine)
- Procardia XL (nifedipine)
- ProFeno (fenoprofen)
- Prograf (tacrolimus)
- Proleukin (aldesleukin)
- Pronestyl (procainamide)
- Pronestyl-SR (procainamide)
- propranolol
- Proprinal (ibuprofen)
- pyrophosphate
More about Angiografin (diatrizoate)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ionic iodinated contrast media
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.